Vitamin D-mediated immune regulation in Multiple Sclerosis

Journal of the Neurological Sciences

Volumn 311, Issue 1-2, 2011, Pages 23-31

  Correale, Jorge ^a   Ysrraelit, María Célica ^a   Gaitán, María Inés ^a  

^a Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

Author keywords

Cytokines; Multiple Sclerosis; Regulatory T cells; T cells; Vitamin D

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; CALCIFEDIOL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; OXYGENASE; VITAMIN D;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE; REMISSION; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM;

ADULT; CHOLECALCIFEROL; COHORT STUDIES; COMORBIDITY; FEMALE; HOMEOSTASIS; HUMANS; IMMUNOMODULATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PRIMARY CELL CULTURE; T-LYMPHOCYTE SUBSETS; VITAMIN D DEFICIENCY;

EID: 81255185227     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.06.027     Document Type: Article

References (56)

1. I.A. van der Mei, A.L. Ponsonby, L. Bizzard, and T. Dwyer Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation Neuroepidemiology 20 2001 168 174 2 (Pubitemid 32718873)
2. K.L. Munger, S.M. Zhang, E. O'Reilly, M.A. Hernán, M.J. Olek, and W.C. Willey Vitamin D intake and incidence of multiple sclerosis Neurology 62 2004 60 65 (Pubitemid 38082871)
3. K.L. Munger, L.I. Levin, B.W. Hollis, N.S. Howard, and A. Ascherio Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis JAMA 296 2006 2832 2838 (Pubitemid 44969183)
4. S. Simpson, B. Taylor, L. Blizzard, A.L. Ponsonby, F. Pittas, and Tremlett Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis Ann Neurol 68 2010 193 203
5. E.M. Mowry, L.B. Krupp, M. Milazzo, D. Chabas, J.B. Strober, and A.L. Belman Vitamin D status is associated with relapse rate in pedriatic-onset multiple sclerosis Ann Neurol 67 2010 618 624
6. J. Correale, M.C. Ysrraelit, and M.I. Gaitan Immunomodulatory effects of Vitamin D in multiple sclerosis Brain 132 2009 1146 1160
7. M. Soilu-Hänninen, M. Laaksonene, I. Laitinen, J.P. Erälinna, E.M. Lilius, and I. Mononen A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis J Neurol Neurosurg Psychiatry 79 2008 152 157 (Pubitemid 351236545)
8. J. Smolders, J. Damoiseaux, P. Menheere, and R. Hupperts Vitamin D as an immune modulator in multiple sclerosis, a review J Neuroimmunol 194 2008 7 17
9. I.A. van der Mei, A.L. Ponsonby, T. Dwyer, L. Blizzard, B.V. Taylor, and T. Kilpatrick Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia J Neurol 254 2007 581 590 (Pubitemid 46781963)
10. J.M. Lemire, and D.C. Archer 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis J Clin Invest 87 1991 1103 1107
11. M.T. Cantorna, C.E. Hayes, and H.F. DeLuca 1,25-Dihydroxyvitamin D3 reversibly blocks the progresión of relapsing encephalomyelitis, a model of multiple sclerosis Proc Natl Acad Sci USA 93 1996 7861 7864 (Pubitemid 26277129)
12. B.M. VanAmerongen, C.D. Dijkstra, P. Lips, and C.H. Polman Multiple sclerosis and vitamin D: an update Eur J Clin Nutr 58 2004 1095 1109 (Pubitemid 39172383)
13. D.H. Munn, M.D. Sharma, J.R. Lee, K.G. Jhaver, T.S. Jonson, and D.B. Kesin Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase Science 297 2002 1867 1870 (Pubitemid 35024345)
14. R. Meisel, A. Zibert, M. Laryea, U. Göbel, W. Daübener, and D. Dilloo Human bone marrow stromal cells inhibit allogenic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation Blood 103 2004 4619 4621 (Pubitemid 38745993)
15. U. Grohmann, F. Fallarino, R. Bianchi, C. Orabona, C. Vacca, and M.C. Fioretti A defect in tryptophan catabolism impairs tolerance to nonobese diabetic mice J Exp Med 198 2003 153 160 (Pubitemid 36870195)
16. F.D. Lublin, and S.C. Reingold Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory committee on clinical trials of new agents in multiple sclerosis Neurology 46 1996 907 911
17. J. Correale, M. McMillan, K. McCarthy, T. Le, and L.P. Weiner Isolation and characterization of autoreactive proteolipid protein-peptide specific T cell clones from multiple sclerosis patients Neurology 45 1995 1370 1378
18. J. Correale, and M. Farez Monocytes derived dendritic cells in multiple sclerosis: the effect of bacterial infections J Neuroimmunol 190 2007 177 189 (Pubitemid 47625616)
19. B. Widner, E.R. Werner, H. Schennach, H. Wachter, and D. Fuchs Simultaneous measurements of serum tryptophan and kynurenin by HPLC Clin Chem 43 1997 2424 2426 (Pubitemid 28022985)
20. C. Lucchinetti, W. Brück, J. Parisi, B. Scheithauer, M. Rodriguez, and H. Lassmann Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination Ann Neurol 47 2000 707 717 (Pubitemid 30390191)
21. A. Kutzelnigg, C. Lucchinetti, C. Stadelmann, W. Brück, H. Rauschka, and M. Bergmann Cortical demyelination and diffuse white matter injury in multiple sclerosis Brain 128 2005 2705 2712 (Pubitemid 41552953)
22. A.J. Thompson, A.G. Kermode, D.G. MacManus, B.E. Kendall, D.P. Kingsley, and I.F. Moseley Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study BMJ 300 1990 631 634 (Pubitemid 20107324)
23. L. Adorini, and G. Penna Control of immune diseases by the Vitamin D endocrine system Nature Clin Pract Rheumat 4 2008 404 412
24. A.W. Norman Receptors for 1-alpha 25(OH)2D3: past, present, and future J Bone Miner Res 13 1998 1360 1369
25. C.M. Veldman, M.T. Cantorna, and H.F. DeLuca Expresión of 1,25-dihydroxyvitamin D3 receptor in the immune system Arch Biochem Biophys 374 2000 334 338 (Pubitemid 30120270)
26. A.W. Norman Minireview: vitamin D receptor: new assignments for an already busy receptor Endocrinology 147 2006 5542 5548 (Pubitemid 44833469)
27. 3 on human B cell differentiation J Immunol 179 2007 1634 1647
28. M. Hewison, F. Burke, K.N. Evans, D.A. Lammas, D.M. Sanson, and P. Liu Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease J Steroid Biochem Mol Biol 103 2007 316 321 (Pubitemid 46420518)
29. M. Hewison, L. Freeman, S.V. Hufghes, K.N. Evans, R. Bland, and A.G. Eliopoulos Differential regulation of Vitamin D receptor and its ligand in human monocyte-derived dendritic cells J Immunol 170 2003 5382 5390 (Pubitemid 36617823)
30. L. Overbergh, K. Stoffels, M. Waer, A. Verstuyf, R. Bouillon, and C. Mathieu Immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in human monocytic THP1 cells: mechanisms of interferon-gamma-mediated induction J Clin Endocrinol Metab 91 2006 3566 3574 (Pubitemid 44402139)
31. 3 in vivo and in primary cultures of chick kidney cells J Biol Chem 254 1979 2722 2729 (Pubitemid 9196105)
32. 3, 1α-hydroxylase gene promoter Proc Natl Acad Sci USA 95 1998 1387 1391
33. X. Dong, W. Lutz, T.M. Shroeder, L.A. Bachman, J.J. Westendorf, and R. Kumar Regulation of relB in dendritic cells by means of modulated association of Vitamin D receptor and histone deacetylase 3 with the promoter Proc Natl Acad Sci USA 102 2005 16007 16012 (Pubitemid 41552858)
34. G. Muthian, H.P. Raikwar, J. Rajasingh, and J.J. Bright 1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 responses in experimental allergic encephalomyelitis J Neurosc Res 83 2006 1299 1309 (Pubitemid 43668013)
35. R. Munker, T. Kobayashi, E. Elstner, A.W. Norman, M. Uskokovic, and W. Zhang A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia Blood 88 1996 2201 2209 (Pubitemid 26307923)
36. P. Li, C. Li, X. Zhao, X. Zhang, S.V. Nicosia, and W. Bai p27 (kip1) stabilization and G(1) arrest by 1,25-dihidroxyvitamin D3 in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-cullin-F-box protein/Skp2 ubiquitin ligase J Biol Chem 279 2004 25260 25267 (Pubitemid 38756778)
37. W. Liu, S.L. Asa, and S. Ezzat Vitamin D and its analog EB1089 induce p27 accumulation and diminish association of p27 with Skp2 independent of PTEN in pituitary corticotrophin cells Brain Pathol 12 2002 412 419 (Pubitemid 35154928)
38. C.G. Mayne, J.A. Spanier, L.M. Relland, C.B. Williams, and C.E. Hayes 1,25-dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis Eur J Immunol 41 2011 822 832
39. G. Penna, and G. Adorini 1 alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation J Immunol 164 2000 2405 2411 (Pubitemid 30115468)
40. L. Adorini, N. Giarratana, and G. Penna Pharmacological induction of tolerogenic dendritic cells and regulatory T cells Semin Immunol 16 2004 127 134 (Pubitemid 38234763)
41. S. Gregori, M. Casorati, S. Amuchastegui, S. Smiroldo, A.M. Davalli, and L. Adorini Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance J Immunol 167 2001 1945 1953 (Pubitemid 32747499)
42. K. Casteels, M. Waer, J. Laureys, D. Valckx, J. Depovere, and R. Bouillon Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine Transplantation 65 1998 1225 1232 (Pubitemid 28224342)
43. I. Alroy, T.L. Towers, and L.P. Freedman Transcriptional repression of the interelukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor Mol Cell Biol 15 1995 5789 5799
44. A. Takeuchi, G.S. Reddy, T. Kobayashi, T. Okano, J. Park, and S. Sharma Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects J Immunol 160 1998 209 218 (Pubitemid 28116731)
45. D. D'Ambrosio, M. Cippitelli, M.G. Cocciolo, D. Mazzeo, P. Di Lucia, and R. Lang Inhibition of IL-12 production by 1,25 dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene J Clin Invest 101 1998 252 262 (Pubitemid 28058925)
46. K.M. Spach, F.E. Nashold, B.N. Dittel, and C.E. Hayes IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis J Immunol 177 2006 6030 6037 (Pubitemid 44628817)
47. G. Penna, S. Amuchastegui, C. Cossetti, F. Aquilano, R. Mariani, and F. Sanvito Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol J Immunol 177 2006 8504 8511 (Pubitemid 44895295)
48. J. Tang, R. Zhou, D. Luger, W. Zhu, P.B. Silver, and R.S. Grajewski Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response J Immunol 182 2009 4624 4632
49. M.T. Cantorna, W.D. Woodward, C.E. Halles, and H.F. DeLuca 1,25-Dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta and IL-4 J Immunol 160 1998 5314 5319 (Pubitemid 28267819)
50. F.E. Nashold, K.A. Hoag, J. Goverman, and C.E. Hayes Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis J Neuroimmunol 119 2001 16 29 (Pubitemid 32781724)
51. B.D. Mahon, A. Wittke, V. Weaver, and M.T. Cantorna The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells J Cell Biochem 89 2003 922 932 (Pubitemid 36927724)
52. L. Adorini Tolerogenic dendritic cells induced by Vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes Ann NY Acad Sci 987 2003 258 261 (Pubitemid 36584031)
53. G. Penna, S. Amuchastegui, N. Giarratana, K.C. Daniel, M. Vulcano, and S. Sozzani 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells J Immunol 178 2007 145 153 (Pubitemid 46033595)
54. T.J. Curiel, G. Coukos, L. Zou, X. Alvarez, P. Cheng, and P. Mottram Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 2004 942 949 (Pubitemid 39273735)
55. J. Correale, M.C. Ysrraelit, and M.I. Gaitán Gender differences in 1,25 dihydroxyvitamin D3 immunomodulaotry effects in multiple sclerosis patients and healthy subjects J Immunol 185 2010 4948 4958
56. K.M. Spach, and C.E. Hates Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice J Immunol 175 2005 4119 4126 (Pubitemid 41292076)